Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.72
+9.9%
$0.99
$0.63
$2.93
$33.72M0.74178,648 shs103,167 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$0.36
+4.0%
$0.42
$0.31
$2.00
$7.02M3.8254,344 shs372,363 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.04
+3.1%
$3.31
$2.66
$5.92
$48.56M1.0958,594 shs64,211 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$10.94
+0.8%
$10.54
$8.26
$11.99
$40.10M0.499,945 shs9,569 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
+9.92%+1.41%-18.14%-54.72%-67.86%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
+4.04%-3.53%-36.49%-2.53%-64.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.05%+8.96%-2.88%-22.45%-36.67%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
+0.83%-4.12%-7.37%+8.32%+458.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.72
+9.9%
$0.99
$0.63
$2.93
$33.72M0.74178,648 shs103,167 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$0.36
+4.0%
$0.42
$0.31
$2.00
$7.02M3.8254,344 shs372,363 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.04
+3.1%
$3.31
$2.66
$5.92
$48.56M1.0958,594 shs64,211 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$10.94
+0.8%
$10.54
$8.26
$11.99
$40.10M0.499,945 shs9,569 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
+9.92%+1.41%-18.14%-54.72%-67.86%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
+4.04%-3.53%-36.49%-2.53%-64.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.05%+8.96%-2.88%-22.45%-36.67%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
+0.83%-4.12%-7.37%+8.32%+458.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50525.00% Upside
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
1.00
SellN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.57
Moderate Buy$6.88126.15% Upside
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
2.20
Hold$28.00155.94% Upside

Current Analyst Ratings Breakdown

Latest NXL, NSPR, SRTS, and STRR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2026
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
DowngradeSell (D-)Sell (E+)
5/20/2026
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
DowngradeHoldStrong Sell
5/8/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
5/6/2026
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
UpgradeSell (E+)Sell (D-)
5/5/2026
InspireMD, Inc. stock logo
NSPR
InspireMD
Reiterated RatingOverweight$4.00 ➝ $3.00
5/4/2026
InspireMD, Inc. stock logo
NSPR
InspireMD
Set Price Target$4.00
4/21/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingSell (D)
(Data available from 6/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.85M3.11N/AN/A$1.83 per share0.39
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$300K24.35N/AN/A$0.20 per share1.78
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M1.82N/AN/A$2.93 per share1.04
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$190.35M0.21$0.64 per share17.12$19.12 per share0.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$8.22M-$0.47N/AN/AN/A-3,018.12%-191.88%-166.43%9/2/2026 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.47N/AN/AN/A-34.50%-15.79%-14.02%8/6/2026 (Estimated)
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$5.92M-$2.63N/A10.52N/A-4.18%-4.04%-2.40%8/6/2026 (Estimated)

Latest NXL, NSPR, SRTS, and STRR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$0.05-$0.99-$1.04-$1.17$52.57 million$50.06 million
5/8/2026Q1 2026
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.11-$0.01-$0.11$0.02 million$0.01 million
5/7/2026Q1 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.16-$0.0350-$0.16$5.32 million$3.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
4.07
3.85
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
7.27
4.03
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.09
2.09
1.84

Institutional Ownership

CompanyInstitutional Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.84%

Insider Ownership

CompanyInsider Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
25.26%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
31.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5046.84 million18.33 millionOptionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
320.58 million15.38 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.46 million14.78 millionOptionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
1,2003.70 million2.53 millionNot Optionable

Recent News About These Companies

Star Equity (NASDAQ:STRR) CEO Buys $26,906.88 in Stock
Star Equity Holdings: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

InspireMD stock logo

InspireMD NYSE:NSPR

$0.72 +0.07 (+9.92%)
Closing price 06/26/2026 04:00 PM Eastern
Extended Trading
$0.72 0.00 (0.00%)
As of 06/26/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$0.36 +0.01 (+4.04%)
Closing price 06/26/2026 04:00 PM Eastern
Extended Trading
$0.37 +0.01 (+3.38%)
As of 06/26/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.04 +0.09 (+3.05%)
Closing price 06/26/2026 04:00 PM Eastern
Extended Trading
$2.96 -0.08 (-2.47%)
As of 06/26/2026 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Star Equity stock logo

Star Equity NASDAQ:STRR

$10.94 +0.09 (+0.83%)
Closing price 06/26/2026 04:00 PM Eastern
Extended Trading
$10.81 -0.13 (-1.19%)
As of 06/26/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.